Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 15 | 2020 | 103 | 4.300 |
Why?
|
| Vitamin D Deficiency | 8 | 2019 | 33 | 1.890 |
Why?
|
| Metabolic Syndrome | 4 | 2022 | 108 | 1.530 |
Why?
|
| Anorectal Malformations | 4 | 2025 | 4 | 1.530 |
Why?
|
| Receptors, Calcitriol | 5 | 2022 | 28 | 1.280 |
Why?
|
| Vitamins | 6 | 2019 | 55 | 1.070 |
Why?
|
| Isothiocyanates | 3 | 2020 | 10 | 1.000 |
Why?
|
| Iron | 7 | 2012 | 126 | 0.990 |
Why?
|
| Dietary Supplements | 8 | 2019 | 167 | 0.980 |
Why?
|
| Rectum | 2 | 2025 | 49 | 0.950 |
Why?
|
| Anal Canal | 1 | 2025 | 22 | 0.900 |
Why?
|
| Sulfoxides | 3 | 2020 | 12 | 0.890 |
Why?
|
| Histone Deacetylases | 3 | 2020 | 59 | 0.860 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 808 | 0.850 |
Why?
|
| Enterocytes | 3 | 2008 | 20 | 0.680 |
Why?
|
| Diet, Carbohydrate-Restricted | 3 | 2014 | 8 | 0.680 |
Why?
|
| Nutritional Status | 5 | 2019 | 79 | 0.660 |
Why?
|
| Calcitriol | 4 | 2008 | 17 | 0.620 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 177 | 0.610 |
Why?
|
| Humans | 43 | 2025 | 40217 | 0.550 |
Why?
|
| Caco-2 Cells | 5 | 2020 | 59 | 0.540 |
Why?
|
| RNA, Messenger | 4 | 2008 | 1254 | 0.500 |
Why?
|
| Pregnancy Outcome | 3 | 2013 | 133 | 0.430 |
Why?
|
| TRPV Cation Channels | 2 | 2020 | 14 | 0.410 |
Why?
|
| Bronchiolitis, Viral | 1 | 2012 | 3 | 0.390 |
Why?
|
| Obesity | 5 | 2018 | 970 | 0.390 |
Why?
|
| Intestinal Absorption | 3 | 2018 | 24 | 0.380 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 30 | 0.380 |
Why?
|
| Iron, Dietary | 4 | 2007 | 8 | 0.370 |
Why?
|
| Ferritins | 6 | 2012 | 25 | 0.370 |
Why?
|
| Diet, Reducing | 1 | 2011 | 23 | 0.360 |
Why?
|
| Vascular Diseases | 1 | 2011 | 35 | 0.360 |
Why?
|
| Female | 21 | 2022 | 20392 | 0.350 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 127 | 0.350 |
Why?
|
| Diet | 3 | 2007 | 440 | 0.340 |
Why?
|
| Bone Density Conservation Agents | 2 | 2009 | 34 | 0.330 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2009 | 3 | 0.320 |
Why?
|
| Fetal Development | 1 | 2009 | 13 | 0.310 |
Why?
|
| Manganese | 1 | 2009 | 20 | 0.310 |
Why?
|
| Trace Elements | 1 | 2009 | 17 | 0.310 |
Why?
|
| Gene Expression | 2 | 2019 | 678 | 0.310 |
Why?
|
| Infant, Newborn | 4 | 2022 | 833 | 0.310 |
Why?
|
| Glycemic Index | 1 | 2009 | 19 | 0.310 |
Why?
|
| Birth Weight | 1 | 2009 | 58 | 0.300 |
Why?
|
| Child | 6 | 2025 | 2856 | 0.290 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2008 | 56 | 0.270 |
Why?
|
| Adipogenesis | 1 | 2008 | 65 | 0.260 |
Why?
|
| Vitamin D3 24-Hydroxylase | 3 | 2020 | 7 | 0.260 |
Why?
|
| Diet, High-Fat | 2 | 2018 | 149 | 0.260 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 22 | 0.260 |
Why?
|
| Pregnancy | 4 | 2022 | 1664 | 0.250 |
Why?
|
| Lipoproteins | 1 | 2006 | 69 | 0.250 |
Why?
|
| Risk Factors | 8 | 2023 | 3141 | 0.250 |
Why?
|
| Weight Loss | 2 | 2014 | 218 | 0.250 |
Why?
|
| Heart Diseases | 2 | 2004 | 109 | 0.250 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 16 | 0.250 |
Why?
|
| Insulin Resistance | 1 | 2009 | 370 | 0.240 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 192 | 0.230 |
Why?
|
| Gastroenterology | 2 | 2024 | 14 | 0.230 |
Why?
|
| Constipation | 1 | 2024 | 9 | 0.230 |
Why?
|
| Hirschsprung Disease | 1 | 2024 | 3 | 0.230 |
Why?
|
| Hypertension | 1 | 2008 | 385 | 0.220 |
Why?
|
| Calcium Channels | 2 | 2020 | 96 | 0.220 |
Why?
|
| Postoperative Complications | 2 | 2025 | 605 | 0.220 |
Why?
|
| Bladder Exstrophy | 1 | 2023 | 1 | 0.210 |
Why?
|
| Vitamin K 1 | 1 | 2003 | 1 | 0.210 |
Why?
|
| Urethral Diseases | 1 | 2023 | 2 | 0.210 |
Why?
|
| Urinary Fistula | 1 | 2023 | 4 | 0.210 |
Why?
|
| Rectal Prolapse | 1 | 2023 | 8 | 0.200 |
Why?
|
| Rectal Fistula | 1 | 2023 | 8 | 0.200 |
Why?
|
| Minerals | 1 | 2003 | 16 | 0.200 |
Why?
|
| Deficiency Diseases | 1 | 2003 | 12 | 0.200 |
Why?
|
| Micronutrients | 1 | 2003 | 18 | 0.200 |
Why?
|
| Calcium, Dietary | 1 | 2002 | 26 | 0.200 |
Why?
|
| Biological Availability | 5 | 2018 | 190 | 0.200 |
Why?
|
| Hemochromatosis | 1 | 2002 | 5 | 0.190 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2002 | 4 | 0.190 |
Why?
|
| Iron-Binding Proteins | 1 | 2002 | 8 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2014 | 505 | 0.190 |
Why?
|
| Arabs | 1 | 2022 | 7 | 0.190 |
Why?
|
| Cation Transport Proteins | 1 | 2002 | 20 | 0.190 |
Why?
|
| Colorectal Neoplasms | 3 | 2011 | 183 | 0.190 |
Why?
|
| Male | 18 | 2023 | 18271 | 0.180 |
Why?
|
| Fecal Incontinence | 1 | 2021 | 16 | 0.180 |
Why?
|
| Aging | 2 | 2003 | 581 | 0.180 |
Why?
|
| Polymorphism, Genetic | 1 | 2022 | 148 | 0.180 |
Why?
|
| Urinary Incontinence | 1 | 2021 | 26 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 326 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 370 | 0.180 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 50 | 0.170 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 18 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 47 | 0.170 |
Why?
|
| Acetylation | 1 | 2020 | 98 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2017 | 730 | 0.160 |
Why?
|
| Treatment Outcome | 2 | 2025 | 2863 | 0.150 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 23 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 368 | 0.150 |
Why?
|
| Intestinal Neoplasms | 1 | 2018 | 10 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2019 | 528 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2022 | 1958 | 0.150 |
Why?
|
| Animals | 10 | 2018 | 16893 | 0.150 |
Why?
|
| Beverages | 2 | 2013 | 61 | 0.150 |
Why?
|
| Parathyroid Hormone | 2 | 2012 | 16 | 0.140 |
Why?
|
| Peptides | 2 | 2017 | 472 | 0.140 |
Why?
|
| United States | 3 | 2021 | 4886 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2017 | 11 | 0.140 |
Why?
|
| Paneth Cells | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 38 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1668 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 64 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 252 | 0.130 |
Why?
|
| Incidence | 2 | 2023 | 773 | 0.130 |
Why?
|
| Cross-Over Studies | 3 | 2013 | 84 | 0.120 |
Why?
|
| Aged | 9 | 2017 | 8182 | 0.120 |
Why?
|
| alpha-Tocopherol | 2 | 2012 | 17 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 503 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 277 | 0.110 |
Why?
|
| Receptors, Transferrin | 2 | 2004 | 30 | 0.110 |
Why?
|
| Inflammation | 2 | 2017 | 912 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2006 | 133 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2014 | 401 | 0.110 |
Why?
|
| beta Carotene | 2 | 2012 | 61 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 410 | 0.110 |
Why?
|
| Adenoma | 2 | 2011 | 45 | 0.100 |
Why?
|
| Cytokines | 1 | 2017 | 721 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 196 | 0.100 |
Why?
|
| Malus | 1 | 2013 | 2 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2023 | 3138 | 0.100 |
Why?
|
| Catechin | 1 | 2013 | 31 | 0.100 |
Why?
|
| Flavonoids | 1 | 2013 | 53 | 0.100 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2012 | 16 | 0.100 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 5 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2012 | 53 | 0.090 |
Why?
|
| Middle Aged | 9 | 2017 | 10090 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2012 | 59 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2013 | 98 | 0.090 |
Why?
|
| Societies, Medical | 2 | 2024 | 158 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 2 | 2009 | 39 | 0.090 |
Why?
|
| Vascular Stiffness | 1 | 2011 | 7 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 289 | 0.090 |
Why?
|
| Prenatal Care | 1 | 2013 | 139 | 0.090 |
Why?
|
| Prevalence | 2 | 2011 | 870 | 0.090 |
Why?
|
| Exercise | 1 | 2017 | 767 | 0.090 |
Why?
|
| Steroid Hydroxylases | 2 | 2008 | 8 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 85 | 0.090 |
Why?
|
| Pneumonia, Viral | 1 | 2012 | 99 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 717 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2017 | 237 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2009 | 4 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2023 | 1203 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 1340 | 0.080 |
Why?
|
| Homeostasis | 1 | 2011 | 305 | 0.080 |
Why?
|
| Sunlight | 1 | 2009 | 27 | 0.080 |
Why?
|
| Area Under Curve | 2 | 2013 | 95 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 249 | 0.080 |
Why?
|
| Bone Density | 1 | 2009 | 94 | 0.070 |
Why?
|
| Energy Intake | 1 | 2009 | 152 | 0.070 |
Why?
|
| Epidemiologic Studies | 1 | 2008 | 30 | 0.070 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2008 | 6 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2007 | 3136 | 0.070 |
Why?
|
| Benzoquinones | 1 | 2008 | 12 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2008 | 18 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2008 | 13 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 59 | 0.070 |
Why?
|
| Meat | 2 | 2011 | 33 | 0.070 |
Why?
|
| Lactams, Macrocyclic | 1 | 2008 | 23 | 0.070 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 82 | 0.070 |
Why?
|
| beta Catenin | 2 | 2018 | 76 | 0.070 |
Why?
|
| Mass Screening | 1 | 2011 | 409 | 0.070 |
Why?
|
| Food, Fortified | 2 | 2009 | 18 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 69 | 0.070 |
Why?
|
| Tretinoin | 1 | 2007 | 37 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 64 | 0.060 |
Why?
|
| Mice | 4 | 2018 | 8809 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 419 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 90 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2017 | 238 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 304 | 0.060 |
Why?
|
| Dactinomycin | 1 | 2005 | 9 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2005 | 18 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2006 | 109 | 0.060 |
Why?
|
| Cholesterol | 1 | 2006 | 225 | 0.060 |
Why?
|
| Triglycerides | 1 | 2006 | 222 | 0.060 |
Why?
|
| Adult | 5 | 2021 | 10255 | 0.060 |
Why?
|
| Preconception Care | 1 | 2004 | 14 | 0.060 |
Why?
|
| Hydroxyl Radical | 1 | 2004 | 7 | 0.060 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2024 | 22 | 0.060 |
Why?
|
| Superoxides | 1 | 2004 | 65 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2024 | 67 | 0.050 |
Why?
|
| Colectomy | 1 | 2024 | 52 | 0.050 |
Why?
|
| Biomarkers | 2 | 2007 | 945 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2004 | 91 | 0.050 |
Why?
|
| Anemia | 1 | 2004 | 84 | 0.050 |
Why?
|
| Protein Binding | 1 | 2008 | 1385 | 0.050 |
Why?
|
| Colostomy | 1 | 2023 | 10 | 0.050 |
Why?
|
| DNA | 1 | 2008 | 691 | 0.050 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 2003 | 1 | 0.050 |
Why?
|
| Anticarcinogenic Agents | 2 | 2018 | 31 | 0.050 |
Why?
|
| Prothrombin | 1 | 2003 | 4 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2006 | 651 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 273 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2004 | 187 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 218 | 0.050 |
Why?
|
| Pediatrics | 1 | 2024 | 159 | 0.050 |
Why?
|
| Tablets | 1 | 2003 | 13 | 0.050 |
Why?
|
| Permeability | 1 | 2003 | 43 | 0.050 |
Why?
|
| Calcium Carbonate | 1 | 2002 | 4 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2004 | 202 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2002 | 26 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 36 | 0.050 |
Why?
|
| Colon | 1 | 2023 | 103 | 0.050 |
Why?
|
| Edible Grain | 1 | 2002 | 25 | 0.050 |
Why?
|
| Milk | 1 | 2002 | 38 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 33 | 0.050 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2002 | 4 | 0.050 |
Why?
|
| Collagen | 1 | 2002 | 87 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 222 | 0.050 |
Why?
|
| Citrus | 1 | 2002 | 41 | 0.050 |
Why?
|
| Hemochromatosis Protein | 1 | 2002 | 3 | 0.050 |
Why?
|
| Fruit | 1 | 2002 | 85 | 0.050 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2002 | 1 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2002 | 36 | 0.050 |
Why?
|
| Food | 1 | 2002 | 68 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 795 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2013 | 367 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 281 | 0.050 |
Why?
|
| Massachusetts | 2 | 2007 | 1701 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2021 | 22 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 532 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 107 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 253 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 2708 | 0.040 |
Why?
|
| North America | 1 | 2021 | 70 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 220 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 989 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 870 | 0.040 |
Why?
|
| Calcium | 1 | 2002 | 497 | 0.040 |
Why?
|
| Transferrin | 2 | 2012 | 67 | 0.040 |
Why?
|
| Liver | 1 | 2003 | 704 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 651 | 0.040 |
Why?
|
| Enteritis | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2002 | 1479 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2008 | 2581 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 279 | 0.040 |
Why?
|
| F2-Isoprostanes | 1 | 2017 | 4 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2012 | 664 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 419 | 0.030 |
Why?
|
| Albuminuria | 1 | 2017 | 17 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 448 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 83 | 0.030 |
Why?
|
| Axin Protein | 1 | 2017 | 7 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 61 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 32 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 154 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 66 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2017 | 11 | 0.030 |
Why?
|
| Muramidase | 1 | 2017 | 39 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 50 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 85 | 0.030 |
Why?
|
| Autophagy | 1 | 2018 | 192 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 114 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 313 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 497 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 236 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 663 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 680 | 0.030 |
Why?
|
| Mutation | 1 | 2002 | 2123 | 0.030 |
Why?
|
| Emulsions | 1 | 2018 | 471 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 732 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2014 | 92 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 127 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1744 | 0.030 |
Why?
|
| Young Adult | 2 | 2012 | 2877 | 0.020 |
Why?
|
| Finland | 1 | 2012 | 16 | 0.020 |
Why?
|
| Placebos | 1 | 2012 | 43 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 124 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 4034 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2012 | 52 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 424 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 140 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 2011 | 13 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2011 | 30 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 600 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 260 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 444 | 0.020 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2009 | 6 | 0.020 |
Why?
|
| Brazil | 1 | 2009 | 43 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1367 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 19 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2007 | 10 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2007 | 9 | 0.020 |
Why?
|
| Carcinogens | 1 | 2007 | 29 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2006 | 5 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 270 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 165 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 585 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2006 | 217 | 0.010 |
Why?
|
| China | 1 | 2004 | 94 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 813 | 0.010 |
Why?
|
| Cebidae | 1 | 2002 | 1 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 1165 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 1691 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 1792 | 0.010 |
Why?
|